Skip to main content
Cardiac device startup gets boost of almost $5M

Phoenix Cardiac has closed an equity financing round at nearly $5 million. The startup intends to use the money to help it gain CE mark approval for its BACE device, which is designed for treating functional mitral valve regurgitation, and aims to launch the product by partnering with a larger company.

Full Story: